# David M. Wood

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/david-m-wood/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,305 |
| Field | Forensic Toxicology and Drug Analysis |
| h-index | 69 |
| i10-index | 243 |
| Last Known Institution | Guy's and St Thomas' NHS Foundation Trust |
| OpenAlex ID | https://openalex.org/A5015960673 |
| ORCID iD | 0000-0002-7826-7237 |
| Works | 401 |

## Researcher papers

- [ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)](https://scholariq.org/papers/esc-eas-guidelines-for-the-management-of-dyslipidaemias-the-task-force-for-the/)
- [Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)](https://scholariq.org/papers/guidelines-on-diabetes-pre-diabetes-and-cardiovascular-diseases-executive/)
- [ESC/EAS Guidelines for the management of dyslipidaemias](https://scholariq.org/papers/esc-eas-guidelines-for-the-management-of-dyslipidaemias/)
- [European guidelines on cardiovascular disease prevention in clinical practice](https://scholariq.org/papers/european-guidelines-on-cardiovascular-disease-prevention-in-clinical-practice/)
- [2,4-Dinitrophenol (DNP): A Weight Loss Agent with Significant Acute Toxicity and Risk of Death](https://scholariq.org/papers/2-4-dinitrophenol-dnp-a-weight-loss-agent-with-significant-acute-toxicity-and/)
- [European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)](https://scholariq.org/papers/european-guidelines-on-cardiovascular-disease-prevention-in-clinical-practice-6/)
- [New psychoactive substances: a review and updates](https://scholariq.org/papers/new-psychoactive-substances-a-review-and-updates/)
- [Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change](https://scholariq.org/papers/mephedrone-use-and-associated-adverse-effects-in-school-and-college-university/)
- [The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use](https://scholariq.org/papers/the-epidemiology-and-patterns-of-acute-and-chronic-toxicity-associated-with/)
- [Case series of individuals with analytically confirmed acute mephedrone toxicity](https://scholariq.org/papers/case-series-of-individuals-with-analytically-confirmed-acute-mephedrone-toxicity/)
- [Clinicians’ perspectives on the use of artificial intelligence to triage MRI brain scans](https://scholariq.org/papers/clinicians-perspectives-on-the-use-of-artificial-intelligence-to-triage-mri/)

## Researcher topics

- [Forensic Toxicology and Drug Analysis](https://scholariq.org/topics/forensic-toxicology-and-drug-analysis/)
- [Poisoning and overdose treatments](https://scholariq.org/topics/poisoning-and-overdose-treatments/)
- [Opioid Use Disorder Treatment](https://scholariq.org/topics/opioid-use-disorder-treatment/)
- [Drug-Induced Hepatotoxicity and Protection](https://scholariq.org/topics/drug-induced-hepatotoxicity-and-protection/)
- [Psychedelics and Drug Studies](https://scholariq.org/topics/psychedelics-and-drug-studies/)

## Researcher university

- [Guy's and St Thomas' NHS Foundation Trust](https://scholariq.org/institutions/guy-s-and-st-thomas-nhs-foundation-trust/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.